Equities

Know Labs Inc

Know Labs Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.372
  • Today's Change0.002 / 0.49%
  • Shares traded179.19k
  • 1 Year change-61.21%
  • Beta1.5232
Data delayed at least 15 minutes, as of Jul 26 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Company’s Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Company’s trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.

  • Revenue in USD (TTM)0.00
  • Net income in USD-20.70m
  • Incorporated1998
  • Employees14.00
  • Location
    Know Labs Inc619 WESTERN AVENUE, SUITE 610SEATTLE 98104United StatesUSA
  • Phone+1 (206) 903-1351
  • Fax+1 (206) 826-0451
  • Websitehttps://www.knowlabs.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Holdco Nuvo Group DG Ltd0.00-3.49m28.21m----0.7798-----0.3581-0.35810.001.090.00-------2.34---2.40--------------0.00-------255.01------
Accelerate Diagnostics Inc12.17m-59.05m28.67m134.00------2.36-4.54-4.540.82-1.180.29782.055.2490,805.97-144.52-75.24---94.4628.3235.08-485.31-638.551.29--2.93---5.4316.291.40--0.7307--
Beyond Air Inc1.16m-60.24m29.15m107.00--1.16--25.15-1.83-1.830.0350.54570.01841.511.9310,831.78-102.29-78.25-145.94-99.91-112.77---5,547.37-6,152.993.61-55.710.3634-----31.57-7.93--152.05--
Cutera Inc196.64m-157.56m30.55m430.00------0.1554-7.89-7.899.86-9.600.48642.294.43457,293.00-38.97-22.00-50.24-30.7216.4247.63-80.13-27.242.22-43.941.84---15.865.47-97.76--85.87--
Positron Corp1.24m-1.27m30.66m22.00------24.79-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Spectral AI Inc19.30m-20.45m31.29m78.00------1.62-1.50-1.501.36-0.1161.30--9.42247,487.20-137.87---601.38--44.78---105.94--0.837--1.54---28.82---616.14------
bioAffinity Technologies Inc4.94m-8.37m31.59m75.00--5.78--6.40-0.9197-0.91970.54160.46870.5334318.228.7065,839.60-90.38---104.93--32.88---169.42--2.21--0.1782--52,660.42--2.66------
Know Labs Inc0.00-20.70m31.81m14.00---------0.3451-0.34510.00-0.02130.00----0.00-254.68-209.16-937.53-1,087.76-------1,302.62---23.611.47---100.00---1.85---3.64--
IRIDEX Corp49.92m-10.94m33.32m111.00--5.14--0.6674-0.6759-0.67593.080.39921.332.667.42449,765.80-29.16-19.54-47.74-27.4640.7242.67-21.92-15.451.03--0.00---8.964.02-26.81---24.35--
Harvard Apparatus Regenertv Tchnlgy Inc160.00k-8.08m33.66m10.00--187.41--210.39-0.5824-0.58240.01150.01260.0474----16,000.00-239.52-330.30-507.69-1,524.8877.50---5,053.13-35,138.840.2558--0.7407-------44.28---39.07--
Retractable Technologies Inc40.20m-7.80m33.83m148.00--0.3402--0.8416-0.2607-0.26071.343.330.21751.545.85271,589.10-4.1012.45-4.3014.5120.2540.82-18.8418.098.18-2.900.0145---54.025.55-249.46--17.42--
iCAD Inc17.94m-5.14m33.97m67.00--1.04--1.89-0.1982-0.08940.69151.230.40810.91992.47267,731.30-11.70-23.94-14.93-34.1485.6076.96-28.66-45.024.59--0.00---12.54-7.5329.32--23.88--
Co-Diagnostics Inc6.68m-38.89m35.74m155.00--0.4471--5.35-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
BioRegenx Inc634.81k-727.95k35.87m10.00--2.11--56.50-0.001-0.0010.00160.01780.0617----63,481.00-7.07---8.46--74.90---114.67--0.1547-8.800.0977---47.25---629.37------
Data as of Jul 26 2024. Currency figures normalised to Know Labs Inc's reporting currency: US Dollar USD

Institutional shareholders

2.79%Per cent of shares held by top holders
HolderShares% Held
Geode Capital Management LLCas of 31 Mar 2024478.38k0.56%
The Vanguard Group, Inc.as of 31 Mar 2024466.49k0.55%
Callan Capital LLCas of 31 Mar 2024370.00k0.43%
Fulcrum Capital LLCas of 30 Jun 2024313.34k0.37%
Corrado Advisors LLCas of 31 Mar 2024207.13k0.24%
PFG Investments LLCas of 31 Mar 2024179.98k0.21%
Foguth Wealth Management LLCas of 30 Jun 2024112.16k0.13%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024100.71k0.12%
Signal Advisors Wealth LLCas of 30 Jun 202483.56k0.10%
Millennium Management LLCas of 31 Mar 202472.10k0.08%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.